CN1326555C - Chinese medicinal powder preparation for treating hepatic ascites - Google Patents

Chinese medicinal powder preparation for treating hepatic ascites Download PDF

Info

Publication number
CN1326555C
CN1326555C CNB2005100463377A CN200510046337A CN1326555C CN 1326555 C CN1326555 C CN 1326555C CN B2005100463377 A CNB2005100463377 A CN B2005100463377A CN 200510046337 A CN200510046337 A CN 200510046337A CN 1326555 C CN1326555 C CN 1326555C
Authority
CN
China
Prior art keywords
present
liver
ascites
cirrhosis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100463377A
Other languages
Chinese (zh)
Other versions
CN1698751A (en
Inventor
姜德连
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100463377A priority Critical patent/CN1326555C/en
Publication of CN1698751A publication Critical patent/CN1698751A/en
Application granted granted Critical
Publication of CN1326555C publication Critical patent/CN1326555C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention belongs to the technical field of Chinese medicine, which relates to a Chinese medicine powder preparation treating liver ascites. The present invention is suitable for treating liver ascites, liver cirrhosis and the fibrous cirrhosis of the liver, which is characterized in that the composition range of the medicine of the present invention is that: 10 to 20g of common prism tuber, 10 to 15g of Zedoary rhizoma curcumae, 25 to 30g of turtle shell, 25 to 30g of tortoise plastron, 10 to 15g of plantain seed, 12 to 15g of magnolia obavata, 12 to 15g of bitter orange, 15 to 20g of green tangerine peel, 25 to 35g of oldenlandia diffusa, and 15 to 20g of areca husk. The medicines are crushed into powder, sieved a sieve with the granularity of 180 meshes and prepared into powder. The results of clinical application indicate that the present invention can be effectively used for treating diseases, such as liver ascites, liver cirrhosis, the fibrous cirrhosis of the liver, etc. The present invention is already used in clinical at present, and treats the patients of more than 1200 cases. By clinical observation, the total effective rate of the present invention reaches over 99 percents, and the cure rate is over 94 percents.

Description

A kind of Chinese powder medicine for the treatment of hepatic ascites
Technical field
The invention belongs to technical field of Chinese medicines, relate to a kind of Chinese powder medicine for the treatment of hepatic ascites, be applicable to hepatic ascites, liver cirrhosis, the hardened treatment of liver fibroid.
Background technology
China is the higher country of hepatopathy sickness rate, and according to statistics, the chronic hepatopathy hepatopath approximately has 1/3rd and develops into the sclerosis of liver fibroid, finally causes liver cirrhosis even hepatocarcinoma.At present, adopt the Drug therapy of classes such as human albumin, interferon at the clinical treatment doctor trained in Western medicine of this disease more, be used to strengthen the immunologic function of human body, improve plasma osmotic pressure, and can not solve liver cirrhosis and the hardened problem of liver fibroid veritably, thereby curative effect is relatively poor.Traditional traditional Chinese medical science adopts blood circulation promoting and blood stasis dispelling, diuretic treatment theory, does not also reach ideal therapeutic effect.
Summary of the invention
The present invention is directed to problems of the prior art, overcome the deficiencies in the prior art, purpose provides a kind of Chinese powder medicine that can effectively treat hepatic ascites, liver cirrhosis, liver fibroid sclerosis disease
A kind of Chinese powder medicine content Description for the treatment of hepatic ascites of the present invention:
A kind of Chinese powder medicine for the treatment of hepatic ascites of the present invention is characterized in that: its crude drug is formed and weight is: rhizoma sparganic 10~20g, Rhizoma Curcumae 10~15g, Carapax Trionycis 25~30g, Carapax et Plastrum Testudinis 25~30g, Semen Plantaginis 10~15g, Cortex Magnoliae Officinalis 12~15g, Fructus Aurantii 12~15g, Pericarpium Citri Reticulatae Viride 15~20g, Herba Hedyotidis Diffusae 25~35g, Pericarpium Arecae 15~20g.
Pharmaceutical formulation each component preferred weight proportioning of the present invention is: rhizoma sparganic 15g, Rhizoma Curcumae 15g, Carapax Trionycis 30g, Carapax et Plastrum Testudinis 30g, Semen Plantaginis 10g, Cortex Magnoliae Officinalis 15g, Fructus Aurantii 15g, Pericarpium Citri Reticulatae Viride 15g, Herba Hedyotidis Diffusae 30g, Pericarpium Arecae 15g;
Said medicine is ground into Powdered, sieves, granularity is 180 orders, makes powder.
A kind of Chinese powder medicine for the treatment of hepatic ascites of the present invention can be used for the treatment of diseases such as hepatic ascites, liver cirrhosis, the sclerosis of liver fibroid effectively by clinical practice result proof.Clinical practice is at present treated example surplus 1200, through the clinical observation total effective rate reach more than 99%, cure rate is more than 94%.Wherein the treatment effective percentage to hepatic ascites patient 520 examples reaches more than 99%, cure rate is 95%; Treatment effective percentage to liver cirrhosis patient 370 examples reaches more than 99%, cure rate is 94%; Treatment effective percentage to liver fibroid sclerosis patient 330 examples reaches more than 99%, cure rate is 96%.
The specific embodiment
The Chinese powder medicine that the present invention treats hepatic ascites is achieved in that by above-mentioned prescription each component optimization formula measures Chinese herbal medicine: rhizoma sparganic 15g, Rhizoma Curcumae 15g, Carapax Trionycis 30g, Carapax et Plastrum Testudinis 30g, Semen Plantaginis 10g, Cortex Magnoliae Officinalis 15g, Fructus Aurantii 15g, Pericarpium Citri Reticulatae Viride 15g, Herba Hedyotidis Diffusae 30g, Pericarpium Arecae 15g;
Said medicine is removed impurity, be ground into Powderedly, sieve, granularity is 180 orders, makes powder.
The oral clinical treatment that is used for, every day is early, middle and late respectively once, each 3g, eliminating cold for resuscitation mouth of a river clothes, one month is a course of treatment, and light patient takes medicine and fully recovers 3~4 courses of treatment, and heavy patient takes medicine and fully recovers 5~6 courses of treatment.
Embodiment 1
Cirrhotic ascites patient: be addicted to drink, lack of appetite, abdominal distention hydrops, complexion are that sallow is dried-up, oliguria, albumin is inverted, and be cirrhotic ascites after diagnosing, obeys western medicine nearly 4 years, the state of an illness repeatedly.Examine in December, 2004, the Chinese powder medicine of oral above-mentioned treatment treatment hepatic ascites is taken 4 courses of treatment of Drug therapy of the present invention, ultrasound diagnosis, and transference cure, disease such as ascites do not occur, have blood in stool now can be engaged in operate as normal.
Embodiment 2
Hepatic ascites swelling patient, abdominal part overflow, many, the trick blue veins evagination of hydrops when examining, abdominal circumference is 93cm, shifting dullness is obvious, rib painful abdominal mass heating installation, receive depressed, the thirst and liking drink of food, skin is scorching hot, bitter taste is dizzy, weak, the facial little Huang of getting into bed less, tongue is white in color, has the long-pending stasis of blood, yellowish urine, constipation, lower limb to be depression, is three phase hepatic ascites after diagnosing.Though repeatedly treat through hospital, lose and be clearly better.Examine in November, 2004, take Drug therapy of the present invention: the Chinese powder medicine of oral above-mentioned treatment treatment hepatic ascites, medication took an evident turn for the better after 3 courses of treatment, continue to take after 2 curative effects on inspection, transference cure, liver function recovery normally, ascites do not appear, facial ruddy, diet has recovered normally can work.
Embodiment 3
Cirrhotic ascites patient: when examining face be smoky gray, abdominal part hydrops, edema of lower limbs, few food, often vomiting, tired out weak, limb is tired, the stomach wall blue veins is prominent cruelly, upper limb has indentation, thready and weak pulse, ultrasound investigation, see the ascites plane, icteric index 50 units, white red eggs are inverted platelet 110,000/mm in vain 3, be cirrhotic ascites companion jaundice after diagnosing.Examine in December, 2004, the Chinese powder medicine of oral above-mentioned treatment treatment hepatic ascites is taken 4 recoveries from illness course of treatment of Drug therapy of the present invention, now can be engaged in operate as normal.
Embodiment 4
Liver cirrhosis patient, liver cirrhosis is seven months when examining, abdominal part overflow, blue veins expose, shape such as frog abdomen, abdominal circumference are 89cm, upper limb is floating, the lower limb bruise, by depression, pale complexion, spiritlessness and weakness, the lack of appetite of receiving advance, polydipsia then expands, extremities being not warm, rib not bitterly, thirsty, the oliguria of mouth, normal, the pale tongue thin fur of stool, be diagnosed as liver cirrhosis.Examine in February, 2005 and to adopt Drug therapy of the present invention: the Chinese powder medicine of oral above-mentioned treatment treatment hepatic ascites, course of treatment of medication, symptom is clearly better, and edema of lower limbs moves back, and the food of receiving is normal, and spirit is also good, can work.

Claims (2)

1, a kind of Chinese powder medicine for the treatment of hepatic ascites is characterized in that: its crude drug is formed and weight is: rhizoma sparganic 10~20g, Rhizoma Curcumae 10~15g, Carapax Trionycis 25~30g, Carapax et Plastrum Testudinis 25~30g, Semen Plantaginis 10~15g, Cortex Magnoliae Officinalis 12~15g, Fructus Aurantii 12~15g, Pericarpium Citri Reticulatae Viride 15~20g, Herba Hedyotidis Diffusae 25~35g, Pericarpium Arecae 15~20g.
2, the Chinese powder medicine of preparation treatment hepatic ascites as claimed in claim 1, it is characterized in that: its crude drug consists of: rhizoma sparganic 15g, Rhizoma Curcumae 15g, Carapax Trionycis 30g, Carapax et Plastrum Testudinis 30g, Semen Plantaginis 10g, Cortex Magnoliae Officinalis 15g, Fructus Aurantii 15g, Pericarpium Citri Reticulatae Viride 15g, Herba Hedyotidis Diffusae 30g, Pericarpium Arecae 15g;
Said medicine is ground into Powdered, sieves, granularity is 180 orders, makes powder.
CNB2005100463377A 2005-04-29 2005-04-29 Chinese medicinal powder preparation for treating hepatic ascites Expired - Fee Related CN1326555C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100463377A CN1326555C (en) 2005-04-29 2005-04-29 Chinese medicinal powder preparation for treating hepatic ascites

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100463377A CN1326555C (en) 2005-04-29 2005-04-29 Chinese medicinal powder preparation for treating hepatic ascites

Publications (2)

Publication Number Publication Date
CN1698751A CN1698751A (en) 2005-11-23
CN1326555C true CN1326555C (en) 2007-07-18

Family

ID=35475104

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100463377A Expired - Fee Related CN1326555C (en) 2005-04-29 2005-04-29 Chinese medicinal powder preparation for treating hepatic ascites

Country Status (1)

Country Link
CN (1) CN1326555C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105194530A (en) * 2014-06-19 2015-12-30 姚本学 Traditional Chinese medicine preparation for treating liver ascites
CN104257848A (en) * 2014-09-16 2015-01-07 赵金芝 Traditional Chinese medicine for treating hepatic ascites

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1211444A (en) * 1998-09-22 1999-03-24 龚晓东 Chinese medicinal powder preparation for treating hepatocirrhosis
CN1277050A (en) * 1999-06-11 2000-12-20 钮自华 Liver ascites treating medicine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1211444A (en) * 1998-09-22 1999-03-24 龚晓东 Chinese medicinal powder preparation for treating hepatocirrhosis
CN1277050A (en) * 1999-06-11 2000-12-20 钮自华 Liver ascites treating medicine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
中西医结合治疗肝腹水82例 赵爱华,中华实用中西医杂志,第3卷第16期 2003 *
软肝煎治疗顽固性肝硬化腹水30例 王京奇等,广西中医药,第25卷第1期 2002 *
软肝煎治疗顽固性肝硬化腹水30例 王京奇等,广西中医药,第25卷第1期 2002;中西医结合治疗肝腹水82例 赵爱华,中华实用中西医杂志,第3卷第16期 2003 *

Also Published As

Publication number Publication date
CN1698751A (en) 2005-11-23

Similar Documents

Publication Publication Date Title
CN103007191B (en) Chinese medicinal composition for treating jaundice
CN103908640A (en) Traditional Chinese medicinal composition for treating liver cirrhosis
CN102512630A (en) Traditional Chinese medicine composition for treating gallbladder calculus
CN102274464B (en) Chinese medicinal composition for treating chronic hepatitis, splenauxe and cirrhosis
CN102362919A (en) Traditional Chinese medicine for treating scleroderma
CN100998722B (en) Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia
CN102198203B (en) Traditional Chinese medicine for treating nonalcoholic fatty liver diseases
CN104288496A (en) Traditional Chinese medicine composition for treating constipation
CN104116971B (en) Traditional Chinese medicine composition for treating liver disease pruritus and preparation method thereof
CN1326555C (en) Chinese medicinal powder preparation for treating hepatic ascites
CN103356932B (en) A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia
CN106138983A (en) Traditional Chinese medicine preparation for treating middle-stage goiter
CN102416146B (en) Chinese medicinal composition for treating amenorrhea
CN101940759A (en) Chinese medicinal composition for treating liver diseases and preparation method and application thereof
CN104547961A (en) Traditional Chinese medicine composition for treating gallstones
CN102920862A (en) Chinese medicinal composition for treating ascites due to cirrhosis
CN102228576B (en) Chinese patent medicine for treating discoid lupus erythematosus
CN101940758A (en) Traditional Chinese medicinal composition for treating liver diseases, preparation method thereof and application thereof
CN102784353B (en) Medicament for treating hepatic cirrhosis ascites
CN105497262A (en) Medicine composition for treating liver-yin and kidney-yin deficiency type polycystic ovarian syndrome
CN102949606A (en) Chinese medicinal composition for treating female climacteric syndrome
CN103494939A (en) Traditional Chinese medicine for treating senile habitual constipation
CN101036742A (en) Medicine for treating prostatic disease
CN1309412C (en) Medicine composition for treating AIDS and preparing method thereof
CN1994415B (en) Orally administered Chinese medicine for treating dysmenorrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070718

Termination date: 20100429